Major Shift in Cannabis Legislation: Medical Marijuana Moves to Schedule III
Updated: Oct 28
Today, the Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) issued an order that shifts medical marijuana from Schedule I of the Controlled Substances Act to Schedule III.
This is not full federal legalization, but it marks the most significant federal action on cannabis in decades.
What This Means for the Industry
For state-licensed medical cannabis operators, this change has immediate and practical effects. Schedule III status almost certainly means the end of IRC § 280E exposure for these businesses. This provision has denied cannabis companies ordinary business deductions for years. Eliminating that burden frees up real operating cash. This could fuel the next wave of mergers and acquisitions (M&A) activity in the cannabis space.
However, for everyone else—recreational operators, unlicensed businesses, and individuals unjustly incarcerated—today's announcement changes little. Marijuana in any other context remains a Schedule I drug, alongside heroin and LSD.
Future Considerations for Cannabis Businesses
Separately, the DOJ announced a new administrative hearing set to begin on June 29, 2026. This hearing will consider the broader rescheduling of all marijuana. The prior Biden-era rulemaking has been scrapped and restarted. The outcome of this process will determine how far these changes go.
This is historic and another step in the right direction. If you hold a state-licensed medical marijuana license, now is the time to revisit your tax structure, financing, exit paths, and overall positioning before the broader rulemaking concludes.
Preparing for the Future
As the landscape of cannabis legislation evolves, it’s crucial to stay informed and prepared. This change could lead to more opportunities for growth and innovation in the industry.
Book a free consult today and make sure your cannabis business is prepared.
The Bigger Picture
This shift in classification is just one piece of a larger puzzle. The conversation around cannabis legalization is growing. As more states move toward legalization, the federal government is also taking steps to catch up.
The implications of this change extend beyond just the financial aspects. It opens the door for more research into cannabis and its benefits. This could lead to better understanding and acceptance of cannabis in society.
A Call to Action
For those in the cannabis industry, it’s essential to adapt to these changes proactively. This is a pivotal moment. Take the time to evaluate your business strategies and ensure you are positioned for success in this evolving landscape.
In conclusion, while we are not at full legalization yet, this movement toward Schedule III is a significant milestone. It’s a chance for cannabis businesses to thrive and for society to embrace the potential benefits of cannabis.
Let’s keep pushing for progress and ensure that we are ready for the opportunities that lie ahead.



Comments